Published 2022 | Version v1
Publication

Potential feasibility of Atezolizumab-Bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

Additional details

Identifiers

URL
https://hdl.handle.net/11567/1093054
URN
urn:oai:iris.unige.it:11567/1093054

Origin repository

Origin repository
UNIGE